Table of Contents
Overview
New York, NY – June 16, 2025 – Global Virus Filtration Market size is expected to be worth around US$ 7.81 billion by 2034 from US$ 3.79 billion in 2024, growing at a CAGR of 7.5% during the forecast period 2025 to 2034. In 2024, North America led the market, achieving over 41.4% share with a revenue of US$ 1.57 Billion.
The virus filtration market is experiencing steady growth driven by increasing concerns over contamination risks in pharmaceutical manufacturing and growing efforts to improve water safety standards. The technology is widely used in the production of biologics, vaccines, and other therapeutic agents to ensure the removal of viral impurities during the purification process.
Regulatory bodies across the globe are enforcing stringent guidelines for virus safety in bioprocessing. As a result, virus filtration has become an essential step in ensuring product purity and compliance. The demand for virus filters has significantly increased, especially within the biopharmaceutical industry, where high product safety standards are required.
Apart from healthcare applications, virus filtration is gaining traction in environmental sectors as part of initiatives to improve public health. Water treatment plants and research laboratories are increasingly adopting virus filtration systems to safeguard against harmful pathogens.
Among the key product types, filter membranes and consumables remain highly preferred due to their efficiency and adaptability in various operational setups. Biopharmaceutical companies continue to lead in terms of end-user adoption.
Geographically, North America holds a prominent position in the market, supported by advanced infrastructure and regulatory support. Meanwhile, Asia-Pacific is emerging as a key growth area due to expanding pharmaceutical manufacturing capacities and rising healthcare awareness.
Key Takeaways
- In 2024, the Virus Filtration market recorded a revenue of US$ 79 billion and is projected to reach US$ 7.81 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.5%.
- The market, by product and services, is categorized into Consumables (including Kits and Reagents), Instruments (Filtration Systems and Chromatography Systems), Filtration Membranes, and Services. Among these, Consumables held the leading position in 2023, accounting for 38.6% of the market share.
- Based on technology, the market is segmented into Ultrafiltration (UF), Microfiltration (MF), Nanofiltration (NF), Chromatography-Based Filtration, and Electropositive Filtration. Ultrafiltration (UF) emerged as the dominant technology with a market share of 35.5%.
- Regarding applications, the market is classified into Biopharmaceuticals, Water Purification, Air Purification, Food and Beverage, Medical Devices, and Gene Therapy. Biopharmaceuticals remained the leading application segment, contributing 37.2% of the total market share.
- By end user, the market is divided into Biopharmaceutical Manufacturers, Contract Manufacturing Organizations (CMOs), Research Laboratories, Hospitals and Healthcare Centers, Medical Device Companies, and Others. Biopharmaceutical Manufacturers led this segment with a 34.0% share.
- Geographically, North America held the dominant regional position in 2023, capturing a market share of 41.4%.
Segmentation Analysis
- Product Analysis: The Consumables segment leads the Virus Filtration market with a 38.6% share, driven by high demand for kits and reagents in laboratories and manufacturing settings. Consumables are essential in virus removal processes across the biotech and healthcare sectors. While smaller in share, instruments and services are growing steadily. Services such as installation and maintenance are increasingly sought after. Filtration membranes are also vital due to their efficiency and reliability in pharmaceutical and water treatment applications.
- Technology Analysis: Ultrafiltration (UF) dominates the technology segment with a 35.5% market share. Its superior pore size and membrane performance make it suitable for pharmaceutical, biotech, and water treatment applications. UF ensures efficient virus removal while maintaining throughput. Microfiltration (MF) is also widely used for capturing larger virus particles, especially in food and beverage processing. Nanofiltration (NF) follows closely, offering effective filtration of smaller contaminants. In March 2025, DuPont launched WAVE PRO for UF system optimization across various water treatment uses.
- Application Analysis: Biopharmaceuticals lead the application segment with a 37.2% share due to the critical need for viral safety in producing biologics, vaccines, and therapeutics. Virus filtration ensures sterility and compliance with regulatory standards. Water purification is the second-largest segment, driven by global concerns about viral contamination in drinking water. Air purification has gained traction post-COVID-19. In October 2024, Asahi Kasei Medical introduced Planova FG1, a high-flux virus removal filter targeting biotherapeutic manufacturing, further boosting this segment.
- End-User Analysis: Biopharmaceutical manufacturers hold the largest share at 34.0%, owing to strict viral safety standards in vaccine and drug production. These manufacturers require high-performance filtration systems to meet regulatory compliance. CMOs follow closely as major users of virus filtration technologies, offering outsourced solutions to pharma firms. In May 2024, Asahi Kasei Medical completed its third assembly plant for Planova virus removal filters in Japan, reflecting rising demand and strengthening its role in global CDMO and biosafety operations.
Market Segments
Product
- Consumables
- Kits and Reagents
- Others
- Instruments
- Filtration Systems
- Chromatography Systems
- Filtration Membranes
- Services
Technology
- Ultrafiltration (UF)
- Microfiltration (MF)
- Nanofiltration (NF)
- Chromatography-Based Filtration
- Electropositive Filtration
Application
- Biopharmaceuticals
- Water Purification
- Air Purification
- Food and Beverage
- Medical Devices
- Gene Therapy
End User
- Biopharmaceutical Manufacturers
- Contract Manufacturing Organizations (CMOs)
- Research Laboratories
- Hospitals and Healthcare Centers
- Medical device companies
- Others
Regional Analysis
North America dominates the virus filtration market due to its robust healthcare infrastructure, strict regulatory framework, and elevated demand for advanced filtration solutions across pharmaceuticals, biotechnology, and healthcare sectors. The region’s strong biopharmaceutical industry significantly contributes to market expansion, as regulatory mandates for virus-free biologics, vaccines, and therapeutic proteins necessitate the adoption of efficient filtration technologies.
The U.S. Food and Drug Administration (FDA), for instance, requires virus filtration in biologic production, reinforcing the region’s regulatory-driven demand. In addition, sustained investments in biotechnology and gene therapy research further support the uptake of advanced virus filtration systems across North America.
The COVID-19 pandemic also intensified the urgency for high-performance air and water filtration technologies, enhancing the market’s regional strength. Furthermore, the presence of key industry leaders such as Merck, Pall Corporation, and Thermo Fisher Scientific—headquartered in North America—reinforces the region’s prominent position in the global virus filtration market.
Emerging Trends
- Wider use of HEPA air cleaners: High-Efficiency Particulate Air (HEPA) filters now capture at least 99.97 % of particles 0.3 µm in size, including those carrying viruses.
- Combined filtration and masking strategies: Studies show that using two HEPA cleaners near a source cuts aerosol exposure by up to 65 %, and when combined with masks, reductions reach 90 %.
- Stronger log-reduction standards in biomanufacturing: Regulatory guidance expects filtration steps to achieve over 3-log (≥ 99.9 %) virus removal, ensuring safety of therapeutic proteins.
- Growth of DIY filtration units: Simple, do-it-yourself air cleaners have been shown to lower aerosol levels by up to 73 %, depending on fan power and filter thickness.
- Enhanced water-based virus removal: Rapid sand filters operated at about 7.5 L/min per m² can remove almost 99 % of enteric viruses like coxsackievirus A5.
Use Cases
- Hospital air management: Fixed HEPA units in patient rooms maintain at least 99.97 % removal of viral particles, reducing airborne transmission in clinical settings.
- Public transit ventilation: Upgrading HVAC filters from MERV-8 to MERV-13 in buses and trains lowers estimated infection probability by about 50 %.
- Vaccine and biologic production: Virus filters validated to deliver at least a 4-log (99.99 %) reduction are used in vaccine bioreactors to clear adventitious agents.
- Municipal water treatment: Sand filtration systems designed per WHO guidelines remove over 99 % of seeded enteric viruses, protecting community water supplies.
- Portable air purification: Stand-alone HEPA cleaners placed in classrooms or offices can cut aerosol exposure by up to 65 %, with further gains when occupants also wear masks.
Conclusion
The virus filtration market is witnessing robust growth, supported by rising contamination concerns, strict regulatory mandates, and expanding biopharmaceutical and water safety needs. Dominated by North America, the market benefits from advanced infrastructure and strong compliance standards. Consumables and ultrafiltration technologies lead due to their efficiency and adaptability.
Emerging trends in air and water filtration, alongside increased use across healthcare and environmental sectors, are reinforcing market expansion. With proven applications in vaccine production, public health, and cleanroom environments, virus filtration remains a critical component in global efforts to ensure safety, sterility, and regulatory compliance across industries.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
